267 related articles for article (PubMed ID: 32537065)
1. Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa.
Maphayi MR; Cassim N; Bello B; George JA
Pan Afr Med J; 2020; 35():61. PubMed ID: 32537065
[TBL] [Abstract][Full Text] [Related]
2. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation of prostate cancer in black South Africans.
Tindall EA; Monare LR; Petersen DC; van Zyl S; Hardie RA; Segone AM; Venter PA; Bornman MS; Hayes VM
Prostate; 2014 Jun; 74(8):880-91. PubMed ID: 24723425
[TBL] [Abstract][Full Text] [Related]
4. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
[TBL] [Abstract][Full Text] [Related]
5. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
7. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.
Howrey BT; Kuo YF; Lin YL; Goodwin JS
J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):56-61. PubMed ID: 22562961
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016.
Cassim N; Rebbeck TR; Glencross DK; George JA
BMJ Open; 2022 Mar; 12(3):e050646. PubMed ID: 35314469
[TBL] [Abstract][Full Text] [Related]
9. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
[TBL] [Abstract][Full Text] [Related]
10. Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
Carver BS; Bozeman CB; Simoneaux WJ; Venable DD; Kattan MW; Eastham JA
J Urol; 2004 Nov; 172(5 Pt 1):1853-5. PubMed ID: 15540737
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
14. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
15. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
16. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer.
Eastham JA; Sartor O; Richey W; Moparty B; Sullivan J
J La State Med Soc; 2001 Apr; 153(4):184-9. PubMed ID: 11394329
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.
Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
[TBL] [Abstract][Full Text] [Related]
20. Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation.
Saltzman AF; Luo S; Scherrer JF; Carson KD; Grubb RL; Hudson MA
Urol Oncol; 2015 Jul; 33(7):330.e9-17. PubMed ID: 25937424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
